Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population
- 29 January 2023
- journal article
- research article
- Published by Springer Nature in The European Journal of Health Economics
- Vol. 25 (1) , 7-19
Abstract
Objectives To explore the comparative performance and develop the mapping algorithms between EQ-5D-5L and SF-6Dv2 in China. Methods Respondents recruited from the Chinese general population completed both EQ-5D-5L and SF-6Dv2 during face-to-face interviews. Ceiling/floor effects were reported. Discriminative validity in self-reported chronic conditions was investigated using the effect sizes (ES). Test–retest reliability was evaluated using intra-class correlation coefficient (ICC) and Bland–Altman plots in a subsample. Correlation and absolute agreements between the two measures were estimated with Spearman’s rank correlation coefficient and ICC, respectively. Ordinary least squares (OLS), generalized linear model, Tobit model, and robust MM-estimator were explored to estimate mapping equations between EQ-5D-5L and SF-6Dv2. Results 3320 respondents (50.3% males; age 18–90 years) were recruited. 51.1% and 12.2% of respondents reported no problems on all EQ-5D-5L and SF-6Dv2 dimensions, respectively. The mean EQ-5D-5L utility was higher than SF-6Dv2 (0.947 vs. 0.827, p < 0.001). Utilities were significantly different across all chronic conditions groups for both measures. The mean absolute difference of utilities between the two tests for EQ-5D-5L was smaller (0.033 vs. 0.043) than SF-6Dv2, with a slightly higher ICC (0.859 vs. 0.827). Fair agreement (ICC = 0.582) was observed in the utilities between the two measures. Mapping algorithms generated by the OLS models performed the best according to the goodness-of-fit indicators. Conclusions Both measures showed comparable discriminative validity. Systematic differences in utilities were found, and on average, the EQ-5D-5L generates higher values than the SF-6Dv2. Mapping algorithms between the EQ-5D-5L and SF-6Dv2 are reported to enable transformations between these two measures in China.Keywords
Funding Information
- National Natural Science Foundation of China (72174142, 71673197)
This publication has 66 references indexed in Scilit:
- Review of studies mapping from quality of life or clinical measures to EQ-5D: an online databaseHealth and Quality of Life Outcomes, 2013
- Using the Multiple Sclerosis Impact Scale to Estimate Health State Utility Values: Mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6DValue in Health, 2012
- t-tests, non-parametric tests, and large studies—a paradox of statistical practice?BMC Medical Research Methodology, 2012
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- The reliability and validity of the Disabilities of Arm, Shoulder, and Hand, EuroQol-5D, Health Utilities Index, and Short Form-6D outcome instruments in patients with proximal humeral fracturesJournal of Shoulder and Elbow Surgery, 2010
- Comparison of 5 Health-Related Quality-of-Life Indexes Using Item Response Theory AnalysisMedical Decision Making, 2009
- A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measuresThe European Journal of Health Economics, 2009
- How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?Annals of the Rheumatic Diseases, 2007
- A comparison of the EQ‐5D and SF‐6D across seven patient groupsHealth Economics, 2004
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990